UWorld Endocrine Practice Test

Calcitonin primarily functions in calcium homeostasis by inhibiting osteoclast activity. Osteoclasts are the cells responsible for bone resorption, a process where bone tissue is broken down, leading to the release of calcium into the bloodstream. When calcitonin is released (typically in response to elevated blood calcium levels), it acts to decrease the activity and number of osteoclasts. This reduction in osteoclast activity decreases the rate of bone resorption, thereby lowering the amount of calcium released into the bloodstream and helping to maintain calcium balance in the body. While dietary calcium absorption, osteoclast enhancement, and renal excretion are also significant factors in calcium homeostasis, they are not directly influenced by calcitonin in the same way. For instance, increasing dietary calcium absorption is primarily facilitated by vitamin D, not calcitonin. Additionally, calcitonin does not enhance osteoclast activity but rather opposes it. Similarly, while renal excretion of calcium can be affected by hormones like parathyroid hormone (PTH), calcitonin mainly focuses on inhibiting osteoclast function in the bone, emphasizing its role in lowering blood calcium levels.